Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase II Rater-Blinded Randomized Controlled Trial to Compare the Effectiveness of Eye Movement Desensitization Reprocessing Therapy vs. Treatment as Usual in Patients With Substance Use Disorder and History of Psychological Trauma

NCT03517592 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.

NCT NCT03517592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03517592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase II Rater-Blinded Randomized Controlled Trial to Compare the Effectiveness of Eye Movement Desensitization Reprocessing Therapy vs. Treatment as Usual in Patients With Substance Use Disorder and History of Psychological Trauma
Lead sponsor
Parc de Salut Mar
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2018
Completion date
November 30, 2022
Enrollment
142 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

substance use disorders